R.E.D. Laboratories Overview

  • Founded
  • 1998
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

R.E.D. Laboratories General Information

Description

Developer of research and diagnostic tests and therapies designed to perform specialty research for chronic immune disorders and intestinal dysfunctions. The company's diagnostic tests and therapies focus on inflammatory mechanisms and offer immune dysfunctions panels, infections-related panels, intestinal dysfunctions panels and autism-related biomedical testing panel, enabling physicians to diagnose and treat patients with complex chronic diseases.

Contact Information

Website
www.redlabs.be
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Discovery Tools (Healthcare)
Primary Office
  • Zone1 Research Park 100
  • 1731 Zellik
  • Belgium
+32 02 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

R.E.D. Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 000.00 Completed Generating Revenue
4. Later Stage VC 04-Sep-2008 00000 000.00 00.000 Completed Generating Revenue
3. Later Stage VC 26-Jun-2003 00000 000.00 00.000 Completed Generating Revenue
2. Early Stage VC 16-Jan-1999 $19.7M $20.9M 00000 Completed Generating Revenue
1. Early Stage VC 01-Feb-1998 $1.16M $1.16M 00.000 Completed Startup
To view R.E.D. Laboratories’s complete valuation and funding history, request access »

R.E.D. Laboratories Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference 000,000 00.00 00.00 00 00.00 00.000
Preference 000,000 00.00 00.00 00 00.00 00.000
To view R.E.D. Laboratories’s complete cap table history, request access »

R.E.D. Laboratories Executive Team (3)

Name Title Board Seat Contact Info
Marc Fremont Chief Scientific Officer
You’re viewing 1 of 3 executive team members. Get the full list »

R.E.D. Laboratories Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R.E.D. Laboratories Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AIM ImmunoTech Corporation Minority 000 0000 000000 0
Bank Corluy Other Minority 000 0000 000000 0
Lessius Corporate Finance Asset Manager Minority 000 0000 000000 0
To view R.E.D. Laboratories’s complete investors history, request access »